Cubist Pharmaceuticals (NASDAQ:CBST)

merck

Merck Is Top DJIA Stock in 2015

Among the 30 stocks that comprise the Dow Jones Industrial Average (DJIA), Merck & Co. Inc. (NYSE: MRK) was among the top performers in 2014, up about 14%, nearly double ...
Read Full Story »
merck

The Bullish and Bearish Case for Merck in 2015

The bull market is almost six years old, and the market gains in 2014 took the Dow Jones Industrial Average up 7.5% and the S&P 500 Index up 11.4%. While ...
Read Full Story »
biotech

After Big Cubist Buy, Are These 2 Stocks Next to Be Acquired?

Merck & Co. Inc.'s (NYSE: MRK) big jump into the antibiotic space with the purchase of Cubist Pharmaceuticals Inc. (NASDAQ: CBST), sporting a 35% premium for shareholders, already has many ...
Read Full Story »
Pills

Merck, Cubist Agree to $9.5 Billion Acquisition

Drug giant Merck & Co. (NYSE: MRK) and Cubist Pharmaceuticals Inc. (NASDAQ: CBST) have signed a definitive merger agreement under which Merck will acquire Cubist for $102 a share, or, ...
Read Full Story »
fda_logo

5 Critical Biotech Drug Dates and Events for December

At least five upcoming dates could be big days in December, for better or worse, for individual biotech stocks. These events refer to reviews and decisions by the U.S. Food ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: AmEx, Apache, Cliffs, Denbury, JetBlue, Synchrony and More

Stocks were weak on Thursday after negative news overseas. Still, investors keep proving that they are willing to buy discounted or overlooked stocks. 24/7 Wall St. reviews dozens of analyst ...
Read Full Story »
buy sell

Top Analyst Upgrades and Downgrades: DuPont, GE, King, Microsoft, Xilinx, McDonald’s and More

Stocks were indicated slightly higher Wednesday morning, after earnings and on hopes that geopolitical risks would abate. Investors still want upside, and they are looking for stocks and sectors where ...
Read Full Story »
Biotechnology word cloud

Top Biotech Earnings Previews for the Week Ahead

Earnings season is now well under way for the second quarter. So far, things are looking good. The biotech sector has yet to see any significant earnings representation. That will ...
Read Full Story »
biotech

As Antibiotics Stop Working, Five Biotechs Seek Cures

One of the main concerns physicians have agreed upon in recent years has been the overuse of antibiotics by some health care professionals. Their overuse in some cases has led ...
Read Full Story »
biotech

Companies Betting on the Next 10 Blockbuster Drugs

The biotech sector has seen its valuations hit hard in many cases in 2014, but many investors remain excited about the future wave of big biotech drugs -- and big ...
Read Full Story »
462542665

Jefferies Stocks to Buy That Could Jump From an Earnings Surprise

The extreme market volatility of the past few weeks has left some investors very nervous. Ongoing selling of technology (Internet) and biotech shares spilled over into the broad market during ...
Read Full Story »
DNA

Ten Top Biotech Merger and Partnership Candidates

One of the ways the big pharmaceutical and biotechnology firms grow their business is through partnerships and acquisitions. That was never more in focus than Thursday when Pfizer lost its ...
Read Full Story »
biotech

Jefferies Top Biotech Stocks to Buy

The world of biotechnology investing is a constantly evolving and changing one. While disease for the most part does not change all that much, the manner in which it can ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Anadarko, Cubist, K12, EOG and More

Earnings season has just started, and investors and traders alike are having to face a government shutdown and a debt ceiling debate painfully developing each day. So which companies and ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Baidu, Cubist, Whole Foods and More

Stocks have seen five days of selling, and investors are deciding which stocks are bargains and which ones will have more downside. 24/7 Wall St. reviews dozens of Wall Street ...
Read Full Story »